Interaction between PAMAM-NH2 G4 dendrimer and 5-fluorouracil in aqueous solution

International Journal of Pharmaceutics

Volumn 408, Issue 1-2, 2011, Pages 266-270

  Buczkowski, Adam ^a   Sekowski, Szymon ^a   Grala, Aleksandra ^a   Palecz, Danuta ^a   Milowska, Katarzyna ^a   Urbaniak, Pawel ^a   Gabryelak, Teresa ^a   Piekarski, Henryk ^a   Palecz, Bartlomiej ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

5 Flurouracil; Equilibrium microdialysis; PAMAM NH2 G4 dendrimer; Solubility enhancement

Indexed keywords

DENDRIMER; FLUOROURACIL; POLYAMIDOAMINE; WATER;

ARTICLE; COMPLEX FORMATION; EQUILIBRIUM CONSTANT; PRIORITY JOURNAL; ROOM TEMPERATURE;

ANTIMETABOLITES, ANTINEOPLASTIC; DENDRIMERS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG INTERACTIONS; FLUOROURACIL; HYDROGEN-ION CONCENTRATION; METHANOL; NYLONS; SOLUBILITY; SOLUTIONS; SOLVENTS; SPECTROPHOTOMETRY; WATER;

EID: 79953241747     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.02.014     Document Type: Article

References (46)

1. Beezer, A.E., King, A.S.H., Martin, I.K., Mitchel, J.C., Twyman, L.J., Wain, C.F., 2003. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives. Tetrahedron 59, 3873-3880. (Pubitemid 36577607)
2. Bhadra, D., Bhadra, S., Jain, S., Jain, N.K., 2003. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 257, 111-124.
3. Bobrovnik, S.A., 2002. Ligand-receptor interaction Klotz-Hunston problem for two classes of binding sites and its solution. J. Biochem. Biophys. Methods 52, 135-143.
4. Boisselier, E., Liang, L., Dalko-Csiba, M., Ruiz, J., Astruc, D., 2010. Interactions and encapsulation of vitamins C, B3, and B6 with dendrimers in water. Chem. Eur. J. 16, 6056-6068.
5. Cakara, D., Borkovec, M., 2007. Microscopic protonation mechanism of branched polyamines: poly(amidoamine) versus poly(propyleneimine) dendrimers. Croat. Chem. Acta 80, 421-428.
6. Cakara, D., Kleimann, J., Borkovec, M., 2003. Microscopic protonation equilibria of poly(amidoamine) dendrimers from macroscopic titrations. Macromolecules 36, 4201-4207.
7. Cheng, Y., Li, M., Xu, T., 2008a. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies. Eur. J. Med. Chem. 43, 1791-1795.
8. Cheng, Y., Wu, Q., Li, Y., Xu, T., 2008b. External electrostatic interaction versus internal encapsulation between cationic dendrimers and negatively charged drugs: which contributes more to solubility enhancement of the drugs? 112, 8884-8890.
9. Cheng, Y., Xu, T., 2005a. Dendrimers as potential drug carriers Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Eur. J. Med. Chem. 40, 1188-1192.
10. Cheng, Y., Xu, T., 2005b. Solubility of nicotinic acid in polyamidoamine dendrimer solutions. Eur. J. Med. Chem. 40, 1384-1389.
11. Cheng, Y., Xu, T., 2008. The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. Eur. J. Med. Chem. 43, 2291-2297.
12. Cheng, Y., Xu, T., Fu, R., 2005. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen. Eur. J. Med. Chem. 40, 1390-1393.
13. Cheng, Y., Xu, Z., Ma, M., Xu, T., 2008c. Dendrimers as drug carriers: applications in different routes of drug administration. J. Pharm. Sci. 97, 123-143.
14. D'Emanuele, A., Attwood, D., 2005. Dendrimer-drug interactions. Adv. Drug Deliv. Rev. 57, 2147-2162.
15. Diallo, M.S., Christie, S., Swaminathan, P., Balogh, L., Shi, X., Um, W., Papelis, C., Goddard, W.A., Johnson, J.H., 2004. Dendritic chelating agents 1. Cu(II) binding to ethylene diamine core poly(amidoamine) dendrimers in aqueous solutions. Langmuir 20, 2640-2651.
16. Esfand, R., Tomalia, D.A., 2001. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. DDT 6, 427-436. (Pubitemid 32328297)
17. Gupta, U., Agashe, H.B., Asthana, A., Jain, N.K., 2006a. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 7, 649-658.
18. Gupta, U., Agashe, H.B., Asthana, A., Jain, N.K., 2006b. A review of in vitro-in vivo investigations on dendrimers: the novel nanoscopic drug carriers. Nanomedicine 2, 66-73. (Pubitemid 43956608)
19. Hu, J., Cheng, Y., Ma, Y., Wu, Q., Xu, T., 2009. Host-guest chemistry and physicochemical properties of the dendrimer-mycophenolic acid complex. J. Phys. Chem. B. 113, 64-74.
20. Jones, L., Atkins, P., 2000. Chemistry. Molecules matter and change. W.H. Freeman and Company, New York.
21. Kolhe, P., Misra, E., Kannan, R.M., Kannan, S., Lieh-Lai, M., 2003. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int. J. Pharm. 259, 143-160.
22. Mallano, A., Zamboni, S., Carpinelli, G., Santoro, F., Flego, M., Ascione, A., Gellini, M., Tombesi, M., Podo, F., Cianfriglia, M., 2008. Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from yeast. BMC Biotechnology 8, 68.
23. Medina, S.H., El-Sayed, M.E.H., 2009. Dendrimers as carriers for delivery of chemotherapeutic agents. Chem. Rev. 109, 3141-3157.
24. Mei, M., Ren, Y., Zhou, X., Yuan, X.-B., Li, F., Jiang, L.-H., Kang, C.-S., Yao, Z., 2009. Suppression of breast cancer cells in vitro by polyamidoamine-dendrimer-mediated 5-fluorouracil chemotherapy combined with antisense micro-RNA 21 gene therapy. J. Appl. Polym. Sci. 114, 3760-3766.
25. Milhem, O.M., Myles, C., McKeown, N.B., Attwood, D., D'Emanuele, A., 2000. Polyamidoamine Starburst dendrimers as solubility enhancers. Int. J. Pharm. 197, 239-241.
26. Munson, P.J., Rodbard, D., 1983. Number of receptor sites from Scatchard and Klotz graphs: a constructive critique. Science 220, 979-981. (Pubitemid 13081941)
27. Najlah, M., D'Emanuele, A., 2006. Crossing cellular barriers using dendrimer nanotechnologies. Curr. Opin. Pharm. 6, 522-527.
28. Niu, Y., Sun, L., Crooks, R.M., 2003. Determination of the intrinsic proton binding constants for poly(amidoamine) dendrimers via potentiometric pH titration. Macromolecules 36, 5725-5731.
29. Patri, A.K., Kukowska-Latallo, J.F., Baker, J.R., 2005. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. Drug Deliv. Rev. 57, 2203-2214.
30. Pavan, G.M., Albertazzi, L., Danani, A., 2010a. Ability to adapt: different generations ofPAMAMdendrimers show different behaviors in binding siRNA. J. Phys. Chem. B 114, 2667-2675.
31. Pavan, G.M., Posocco, P., Tagliabue, A., Maly, M., Malek, A., Danani, A., Ragg, E., Catapano, C.V., Pricl, S., 2010b. PAMAM dendrimers for siRNA delivery: computational and experimental insights. Chem. Eur. J. 16, 7781-7795.
32. Peng, S.-F., Su, C.-J., Wei, M.-C., Chen, C.-Y., Liao, Z.-X., Lee, P.-W., Chen, H.-L., Sung, H.-W., 2010. Effects of the nanostructure of dendrimer/DNA complexes on their endocytosis and gene expression. Biomaterials 31, 5660-5670.
33. Scatchard, G., 1949. The attractions of proteins for small molecules and ions. Ann. N Y Acad. Sci. 51, 660-672.
34. 2+ complexes and human serum albumin. Colloids Surf. B: Biointerfaces 69, 95-98.
35. Shakhbazau, A., Isayenka, I., Kartel, N., Goncharova, N., Seviaryn, I., Kosmacheva, S., Potapnev, M., Shcharbin, D., Bryszewska, M., 2010. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity. Int. J. Pharm. 383, 228-235.
36. Shcharbin, D., Mazur, J., Szwedzka, M., Wasiak, M., Palecz, B., Przybyszewska, M., Zaborski, M., Bryszewska, M., 2007. Interaction betweenPAMAM4.5 dendrimer, cadmiumand bovine serum albumin: a study using equilibrium dialysis, isothermal titration calorimetry, zeta-potential and fluorescence. Colloids Surf. B: Biointerfaces 58, 286-289. (Pubitemid 46921468)
37. Singh, B.N., 2005. A quantitative approach to probe the dependence and correlation of food-effect with aqueous solubility, dose/solubility ratio, and partition coefficient (Log P) for orally active drugs administered as immediate-release formulations. Drug Develop. Res. 65, 55-75.
38. Singh, P., Gupta, U., Asthana, A., Jain, N.K., 2008. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjugate Chem. 19, 2239-2252.
39. Svenson, S., Tomalia, D.A., 2005. Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev. 57, 2106-2129.
40. Thomas, T.P., Choi, S.K., Li, M.-H., Kotlyar, A., Baker, J.R., 2010. Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery. Bioorg. Med. Chem. Lett. 20, 5191-5194.
41. Venuganti, V.V.K., Perumal, O.P., 2008. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. Int. J. Pharm. 361, 230-238.
42. Venuganti, V.V.K., Perumal, O.P., 2009. Poly(amidoamine) dendrimers as skin penetration enhancers: influence of charge, generation and concentration. J. Pharm. Sci. 98, 2345-2356.
43. Wang, P., Zhao, X.-H., Wang, Z.-Y., Meng, M., Li, X., Ning, Q. Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment. Cancer Lett., in press.
44. Yang, W., Li, Y., Cheng, Y., Wu, Q., Wen, L., Xu, T., 2009. Evaluation of phenylbutazone and poly(amidoamine) dendrimers interactions by a combination of solubility, 2D-NOESY NMR, and isothermal titration calorimetry studies. J. Pharm. Sci. 98, 1075-1085.
45. Zeng, F., Zimmerman, S.C., 1997. Dendrimers in supramolecular chemistry: from molecular recognition to self-assembly. Chem. Rev. 97, 1681-1712.
46. Zhuo, R.X., Du, B., Lu, Z.R., 1999. In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J. Contr. Release 57, 249-257.